valine has been researched along with HIV in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Dehghan Manshadi, SA; Kalantari, S; Karimi, J; Malekzadeh, R; Malekzadeh, Z; Mardani, M; Merat, D; Merat, S; Mirminachi, B; Mohraz, M; Nikbin, M; Norouzi, A; Poustchi, H; Rasoolinejad, M; Sali, S; Sedghi, R; Sharifi, AH; Somi, MH; Tabarsi, P; Tayeri, K | 1 |
| Komatsu, H; Miyata, N; Tachikawa, N; Yoshimura, Y | 1 |
| Fan, H; Fu, Z; Huang, P; Tian, T; Wang, Y; Wu, J; Xia, X; Ye, X; Yue, M; Zhang, Y | 1 |
| Chieza, L; Huibner, S; Kaul, R; Raboud, J; Remis, R; Saunders, M; Shannon, B; Su, D; Tharao, W; Yi, TJ | 1 |
| Kohli, RM; Lai, J; Liu, JO; McMahon, MA; Siliciano, JD; Siliciano, RF; Stivers, JT | 1 |
| Frank, I; Robbiani, M | 1 |
| Bartlett, JG | 1 |
| Colonno, RJ; Dufour, J; Hu, Q; Ketas, TJ; Klasse, PJ; Lu, M; Marx, PA; Moore, JP; Schader, SM; Shattock, RJ; Springer, MS; Veazey, RS | 1 |
| Bilang, M; Meyer, B; Neffe, AT | 1 |
| Boothby, M; Radcliffe, K | 1 |
| Gozlan, M | 1 |
| Antonelli, G; Dianzani, F; Jacobsen, H; Mous, J; Pistello, M; Riva, E; Turriziani, O | 1 |
| Cohen, J | 2 |
| Boucher, CA; Chernyavskiy, T; Gao, Q; Granneman, GR; Ho, DD; Hsu, A; Kempf, DJ; Korneyeva, M; Leonard, JM; Lyons, N; Markowitz, M; Mo, HM; Molla, A; Niu, P; Norbeck, DW; Schipper, PJ; Vasavanonda, S | 1 |
| Phillips, L | 1 |
| Chang, HE | 1 |
| Torres, G | 1 |
| James, JS | 1 |
| Smart, T | 1 |
| Mascolini, M | 1 |
1 review(s) available for valine and HIV
| Article | Year |
|---|---|
Recent developments in the management of herpes simplex virus infection in HIV-infected persons.
Topics: Acyclovir; Antiviral Agents; Herpes Genitalis; Herpesvirus 2, Human; HIV; HIV Infections; Humans; Secondary Prevention; Valacyclovir; Valine | 2004 |
2 trial(s) available for valine and HIV
| Article | Year |
|---|---|
Valacyclovir therapy does not reverse herpes-associated alterations in cervical immunology: a randomized, placebo-controlled crossover trial.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Canada; CD4-Positive T-Lymphocytes; Cervix Uteri; Cross-Over Studies; Cytokines; Dendritic Cells; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV; Humans; Leukocyte Count; Middle Aged; Placebos; Treatment Outcome; Valacyclovir; Valine; Young Adult | 2014 |
Opportunistic infection highlights from the 35th ICAAC.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Ganciclovir; HIV; Humans; Influenza Vaccines; Mycobacterium avium-intracellulare Infection; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; United States; Valacyclovir; Valine; Viremia | 1995 |
20 other study(ies) available for valine and HIV
| Article | Year |
|---|---|
Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virus.
Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Imidazoles; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine | 2021 |
Remarkable plasma HIV RNA decrease by ombitasvir/paritaprevir/ritonavir in an HIV-HCV coinfection case.
Topics: Adult; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Plasma; Proline; Ritonavir; RNA, Viral; Sulfonamides; Valine; Viral Load | 2018 |
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Clinical Trials as Topic; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Observational Studies as Topic; Proline; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2019 |
The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Multiple, Viral; HIV; HIV Reverse Transcriptase; Mutation; Simplexvirus; Substrate Specificity; Valine; Virus Replication | 2008 |
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection.
Topics: Anti-HIV Agents; Cells, Cultured; Coculture Techniques; Dendritic Cells; HIV; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; Humans; Peptide Fragments; Pyrazoles; T-Lymphocytes; Valine; Virus Replication | 2011 |
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; CD4 Antigens; Cell Fusion; Drug Therapy, Combination; Female; HIV; HIV Envelope Protein gp120; HIV Infections; Macaca mulatta; Membrane Fusion; Piperazines; Pyrazoles; Receptors, CCR5; Receptors, Virus; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Vagina; Valine | 2005 |
Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking.
Topics: Binding Sites; CD4 Antigens; Databases, Protein; Glycine; HIV; Ligands; Lysine; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Oligopeptides; Peptides; Proline; Threonine; Valine | 2006 |
An unusual vulval lesion in an HIV-infected woman.
Topics: Acyclovir; Adolescent; Anti-Retroviral Agents; Drug Resistance, Viral; Female; Herpes Simplex; HIV; HIV Infections; Humans; Pregnancy; Simplexvirus; Valacyclovir; Valine; Vulvar Diseases | 2007 |
Update on HIV transmission and pathogenesis.
Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Disease Models, Animal; Genes, env; HIV; HIV Infections; HIV Protease Inhibitors; HIV-1; HLA-A Antigens; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Macaca; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Simian Immunodeficiency Virus; Thiazoles; Time Factors; Valine; Virulence; Virus Latency; Virus Replication | 1995 |
Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase.
Topics: Base Sequence; DNA Primers; Drug Resistance, Microbial; Glycine; HIV; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Molecular Sequence Data; Mutation; Quinolines; Saquinavir; Valine; Viral Proteins | 1994 |
Results on new AIDS drugs bring cautious optimism.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; RNA, Viral; Thiazoles; Valine; Viremia | 1996 |
Protease inhibitors: a tale of two companies.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Chemistry, Pharmaceutical; Controlled Clinical Trials as Topic; Drug Approval; Drug Design; Drug Industry; HIV; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; Thiazoles; United States; United States Food and Drug Administration; Valine | 1996 |
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir.
Topics: Codon; Genotype; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Mutation; Phenotype; Ritonavir; Thiazoles; Valine | 1996 |
Antiretroviral drugs: new agents, new combinations line up against HIV.
Topics: Antiviral Agents; Australia; Didanosine; Drug Therapy, Combination; Europe; HIV; HIV Infections; Humans; Lamivudine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ritonavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine | 1996 |
Protease inhibitor trials moving to next phase.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Nelfinavir; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication | 1995 |
Abbott protease inhibitor in combination: sustained viral load drop.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Ritonavir; RNA, Viral; Thiazoles; Valine | 1995 |
Conference looks at HIV drug resistance.
Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine | 1995 |
Protease inhibitors: patient education critical.
Topics: Acquired Immunodeficiency Syndrome; Drug Interactions; Drug Resistance, Microbial; HIV; HIV Protease Inhibitors; Humans; Indinavir; Patient Education as Topic; Pyridines; Ritonavir; Thiazoles; Valine | 1996 |
Nipping HIV in the bud.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication; Zalcitabine; Zidovudine | 1996 |
Ritonavir plus saquinavir: two trials with different results.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; RNA, Viral; Saquinavir; Thiazoles; Valine | 1996 |